HARVARD BIOSCIENCE INC — Director's Dealing 2024

Jun 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2024-06-06

Reporting Person: Green James W (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-06	Common Stock	P	20000	$3.07	Acquired	3101091	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $3.03 to $3.12, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: Includes (a) 235,427 RSUs that will vest in two equal installments on December 29, 2024 and 2025, (b) 52,346 RSUs that will vest on December 29, 2024, (c) 214,797 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (d) 699,772 RSUs with performance based vesting conditions and (e) 1,898,749 shares of common stock beneficially owned by the Reporting Person.